# Application of Citicoline in Neurological Disorders: A Systematic Review

**Authors:** Patryk Jasielski, Faustyna Piędel, Mikołaj Piwek, Agata Rocka, Véronique Petit, Konrad Rejdak

PMC · DOI: 10.3390/nu12103113 · 2020-10-12

## TL;DR

Citicoline may help treat neurological disorders and improve cognitive functions, though its effects on brain trauma remain unclear.

## Contribution

A systematic review of citicoline's effects in neurological diseases, highlighting its potential for cognitive enhancement and stroke recovery.

## Key findings

- Citicoline helps prevent dementia progression and improves cognitive functions in healthy individuals.
- It improves prognosis after stroke and stimulates nerve regeneration in animal models.
- Its clinical effect on brain trauma remains unclear.

## Abstract

Citicoline is a chemical compound involved in the synthesis of cell membranes. It also has other, not yet explained functions. Research on the use of citicoline is conducted in neurology, ophthalmology, and psychiatry. Citicoline is widely available as a dietary supplement. It is often used to enhance cognitive functions. In our article, accessible databases were searched for articles regarding citicoline use in neurological diseases. This article has a systemic review form. After rejecting non-eligible reports, 47 remaining articles were reviewed. The review found that citicoline has been proven to be a useful compound in preventing dementia progression. It also enhances cognitive functions among healthy individuals and improves prognosis after stroke. In an animal model of nerve damage and neuropathy, citicoline stimulated regeneration and lessened pain. Among patients who underwent brain trauma, citicoline has an unclear clinical effect. Citicoline has a wide range of effects and could be an essential substance in the treatment of many neurological diseases. Its positive impact on learning and cognitive functions among the healthy population is also worth noting.

## Linked entities

- **Chemicals:** citicoline (PubChem CID 13804)
- **Diseases:** dementia (MONDO:0001627), stroke (MONDO:0005098), neuropathy (MONDO:0005244), brain trauma (MONDO:0043510)

## Full-text entities

- **Genes:** PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, AHSG (alpha 2-HS glycoprotein) [NCBI Gene 197] {aka A2HS, AHS, APMR1, FETUA, HSGA}, Sirt1 (sirtuin 1) [NCBI Gene 309757] {aka Sir2}, MGP (matrix Gla protein) [NCBI Gene 4256] {aka GIG36, MGLAP, NTI}, AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}
- **Diseases:** body (MESH:D001835), impulsiveness reduction (MESH:D007174), diabetes (MESH:D003920), hemorrhagic stroke (MESH:D000083302), neuropsychiatric symptoms (MESH:D001523), organism (MESH:D000092124), Parkinson's (MESH:D010300), ischemic stroke (MESH:D002544), amblyopia (MESH:D000550), polyneuropathies (MESH:D011115), inflammatory pain (MESH:D010146), Dementia (MESH:D003704), neurological complications (MESH:D002493), atherosclerosis (MESH:D050197), inflammation (MESH:D007249), somatoform disorders (MESH:D013001), Mortality (MESH:D003643), atrial fibrillation (MESH:D001281), sciatic nerve injury (MESH:D020426), toxicity (MESH:D064420), neuroinflammation (MESH:D000090862), AD (MESH:D000544), Head injuries (MESH:D006259), Injury (MESH:D014947), neuronal damage (MESH:D009410), nerve (MESH:C537568), Coma (MESH:D003128), Depression (MESH:D003866), attention betterment (MESH:D001289), Stroke (MESH:D020521), brain damage (MESH:D001925), neurological diseases (MESH:D020271), nerve damage (MESH:D000080902), Neurological Disorders (MESH:D009461), Brain Injury (MESH:D001930), Cognitive Functions (MESH:D003072), ischemia (MESH:D007511), Neuropathic Pain (MESH:D009437), hypoxia (MESH:D000860), ischemic lesions (MESH:D017202), neurodegenerative diseases (MESH:D019636), Peripheral Nerves (MESH:D010523), Brain Stroke (MESH:D001927), ischemic and hemorrhagic stroke (MESH:D002543), TBI (MESH:D000070642), brain tissue damage (MESH:D017695), glaucoma (MESH:D005901), vascular dementia (MESH:D015140), mood and (MESH:D019964), neurological and non-neurological diseases (MESH:D009422),  (MESH:D004195)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC7601330/full.md

---
Source: https://tomesphere.com/paper/PMC7601330